# Ascribe Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ascribe-bioscience

- Industry: Agribusiness
- Headquarters: Ithaca, US
- Website: www.ascribebio.com
- Total disclosed funding: $18M
- Latest round: Series A (Oct 8, 2025)
- Investors on record: 8

## About

Founded in 2017 and based in New York, US, Ascribe Bioscience operates as a developer of natural crop protection based on small molecules in the soil microbiome that helps to protect their products without destroying the environment.

## Funding rounds

- Series A, Oct 8, 2025, $15M — Cultivation Capital, Syngenta Ventures, Acre Venture Partners, The Yield Lab, Trailhead Capital, Silver Blue LLC, Corteva Agriscience Defined Benefit Pension Plan
- Seed, Aug 27, 2021, $2.5M — Acre Venture Partners, The Yield Lab, Trailhead Capital, Ponderosa Ventures

## Investors

- Acre Venture Partners (https://capitalatlas.ai/funds/acre-venture-partners) — Seed, Series A
- The Yield Lab (https://capitalatlas.ai/funds/the-yield-lab) — Seed, Series A
- Trailhead Capital (https://capitalatlas.ai/funds/trailhead-capital) — Seed, Series A
- Ponderosa Ventures (https://capitalatlas.ai/funds/ponderosa-ventures) — Seed
- Cultivation Capital (https://capitalatlas.ai/funds/cultivation-capital) — Series A
- Syngenta Ventures (https://capitalatlas.ai/funds/syngenta-ventures) — Series A
- Silver Blue LLC — Series A
- Corteva Agriscience Defined Benefit Pension Plan — Series A